Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 23596300)

1.

Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses.

Tomov VT, Osborne LC, Dolfi DV, Sonnenberg GF, Monticelli LA, Mansfield K, Virgin HW, Artis D, Wherry EJ.

J Virol. 2013 Jun;87(12):7015-31. doi: 10.1128/JVI.03389-12. Epub 2013 Apr 17.

2.

Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.

Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW.

PLoS Pathog. 2008 Dec;4(12):e1000236. doi: 10.1371/journal.ppat.1000236. Epub 2008 Dec 12.

3.

Identification of cross-reactive norovirus CD4+ T cell epitopes.

LoBue AD, Lindesmith LC, Baric RS.

J Virol. 2010 Sep;84(17):8530-8. doi: 10.1128/JVI.00727-10. Epub 2010 Jun 23.

4.

Investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection.

Doom CM, Turula HM, Hill AB.

Virology. 2009 Sep 30;392(2):153-61. doi: 10.1016/j.virol.2009.05.035. Epub 2009 Aug 3.

5.

Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology.

Kahan SM, Liu G, Reinhard MK, Hsu CC, Livingston RS, Karst SM.

Virology. 2011 Dec 20;421(2):202-10. doi: 10.1016/j.virol.2011.09.030. Epub 2011 Oct 22.

6.

Antibody is critical for the clearance of murine norovirus infection.

Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW 4th.

J Virol. 2008 Jul;82(13):6610-7. doi: 10.1128/JVI.00141-08. Epub 2008 Apr 16.

7.

Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus.

Hensley SE, Pinto AK, Hickman HD, Kastenmayer RJ, Bennink JR, Virgin HW, Yewdell JW.

J Virol. 2009 Jul;83(14):7357-60. doi: 10.1128/JVI.00623-09. Epub 2009 Apr 29.

8.

Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses.

Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM.

J Virol. 2007 Apr;81(7):3251-63. Epub 2007 Jan 17.

9.

Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains.

Zhu S, Regev D, Watanabe M, Hickman D, Moussatche N, Jesus DM, Kahan SM, Napthine S, Brierley I, Hunter RN 3rd, Devabhaktuni D, Jones MK, Karst SM.

PLoS Pathog. 2013;9(9):e1003592. doi: 10.1371/journal.ppat.1003592. Epub 2013 Sep 5.

10.

Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS.

J Virol. 2009 Apr;83(7):3212-27. doi: 10.1128/JVI.01650-08. Epub 2009 Jan 28.

11.

MDA-5 recognition of a murine norovirus.

McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M.

PLoS Pathog. 2008 Jul 18;4(7):e1000108. doi: 10.1371/journal.ppat.1000108. Erratum in: PLoS Pathog. 2008 Oct;4(10). doi:10.1371/annotation/3ce83911-9ccf-4452-a690-2816d0e94c10.. Virgin Iv, Herbert W [corrected to Virgin, Herbert W].

12.

Multiple effects of dendritic cell depletion on murine norovirus infection.

Elftman MD, Gonzalez-Hernandez MB, Kamada N, Perkins C, Henderson KS, Núñez G, Wobus CE.

J Gen Virol. 2013 Aug;94(Pt 8):1761-8. doi: 10.1099/vir.0.052134-0. Epub 2013 May 1.

13.
14.

Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus.

Liu G, Kahan SM, Jia Y, Karst SM.

J Virol. 2009 Jul;83(13):6963-8. doi: 10.1128/JVI.00284-09. Epub 2009 Apr 29.

15.

Cellular and humoral immunity following Snow Mountain virus challenge.

Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, Baric RS.

J Virol. 2005 Mar;79(5):2900-9.

16.

[MHC tetramers: tracking specific immunity].

Kosor E, Gagro A, Drazenović V, Kuzman I, Jeren T, Rakusić S, Rabatić S, Markotić A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacić V, Gjenero-Margan I, Kaić B, Mlinarić-Galinović G, Kastelan A, Dekaris D.

Acta Med Croatica. 2003;57(4):255-9. Review. Croatian.

PMID:
14639858
17.

Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection.

Pope C, Kim SK, Marzo A, Masopust D, Williams K, Jiang J, Shen H, Lefrançois L.

J Immunol. 2001 Mar 1;166(5):3402-9. Erratum in: J Immunol 2001 May 1;166(9):5840.

18.

Murine norovirus, a recently discovered and highly prevalent viral agent of mice.

Henderson KS.

Lab Anim (NY). 2008 Jul;37(7):314-20. doi: 10.1038/laban0708-314. Review.

PMID:
18568010
19.

Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, Diamond MS, Virgin HW.

Science. 2015 Jan 16;347(6219):269-73. doi: 10.1126/science.1258100. Epub 2014 Nov 27.

PMID:
25431489
20.

Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.

Guo L, Wang J, Zhou H, Si H, Wang M, Song J, Han B, Shu Y, Ren L, Qu J, Hung T.

Vaccine. 2008 Jan 24;26(4):460-8. Epub 2007 Dec 4.

PMID:
18160189
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk